Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Dikelele Elessa, MD, Stephanie Harel, MD, Alexis Talbot, MD, Marion Malphettes, MD, Catherine Thieblemont, MD PhD, Frederic Davi, MD PhD, Odile Maarek, MD, Bertrand Arnulf, MD PhD, Bruno Royer, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137592

Published: 2020

Journal Articles

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Alexis Talbot, MD, Laurence Gérard, MD, Raphael Szalat, MD, David Boutboul, Stephanie Harel, MD, Anne Lazareth, Marion Malphettes, MD, PhD, Bouchra Asli, MD, Lionel Galicier, MD, Claire Fieschi, MD, PhD, Eric Oksenhendler, MD, Jean Paul Fermand, MD, Bertrand Arnulf, MD, PhD

Blood (2013) 122 (21): 5348.

https://doi.org/10.1182/blood.V122.21.5348.5348

Published: 2013

Journal Articles

Impact of Tandem Autologous/Non Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose Therapy in the Era of Novels Anti-Myeloma Agents

Stephanie Harel, MD, Sophie Bernard, Sylvie Chevret, Regis Peffault de Latour, Lionel Karlin, MD, Marie Robin, MD, PhD, Lionel Ades, MD, PhD, Raphael Szalat, MD, Marion Malphette, Bouchra Asli, MD, Jean Paul Fermand, MD, Bertrand Arnulf, MD, PhD, Gerard Socie

Blood (2012) 120 (21): 2035.

https://doi.org/10.1182/blood.V120.21.2035.2035

Published: 2012

Journal Articles

Prognostic Value of the Different MMSET Gene Breakpoints and Correlation with Immunoglobulin Isotype and FGFR3 Expression in 173 Patients with t(4;14) Multiple Myeloma

Bertrand Arnulf, MD, PhD, Anne Lazareth, Jean Soulier, MD, PhD, Stephanie Harel, MD, Lionel Karlin, MD, Damien Roosweil, Karim Belhadj, Jerome Tamburini, Arnaud Jaccard, Raphael Szalat, Bouchra Asli, MD, Marion Malphettes, MD, PhD, jean Christophe Bories, Jean Paul Fermand, MD

Blood (2012) 120 (21): 3971.

https://doi.org/10.1182/blood.V120.21.3971.3971

Published: 2012

Journal Articles

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Evangelos Terpos, Meletios Athanasios Dimopoulos, MD, Stephanie Harel, MD, Francis K Buadi, M.D., Dimitrios Christoulas, Ersi Voskaridou, Efstathios Kastritis, Jean Paul Fermand, MD, Angela Dispenzieri, MD

Blood (2011) 118 (21): 806.

https://doi.org/10.1182/blood.V118.21.806.806

Published: 2011

Journal Articles

Total Body Irradiation (TBI) or Busulfan (Bu) Plus High Dose Melphalan After Bortezomib (Bz) Containing Regimen As Front Line Treatment of High Risk Multiple Myeloma (MM) Patients with 17p Deletion and/or t(4;14) Translocation

Bertrand Arnulf, MD, PhD, Raphael Szalat, MD, Lionel Karlin, MD, Stephanie Harel, MD, Bouchra Asli, MD, Marion Malphettes, MD, PhD, Jean Soulier, MD, Jean Paul Fermand, MD

Blood (2011) 118 (21): 4501.

https://doi.org/10.1182/blood.V118.21.4501.4501

Published: 2011

NARROW

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Impact of Tandem Autologous/Non Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose Therapy in the Era of Novels Anti-Myeloma Agents

Prognostic Value of the Different MMSET Gene Breakpoints and Correlation with Immunoglobulin Isotype and FGFR3 Expression in 173 Patients with t(4;14) Multiple Myeloma

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Total Body Irradiation (TBI) or Busulfan (Bu) Plus High Dose Melphalan After Bortezomib (Bz) Containing Regimen As Front Line Treatment of High Risk Multiple Myeloma (MM) Patients with 17p Deletion and/or t(4;14) Translocation

Email alerts

ASH Publications

American Society of Hematology

A Retrospective Study of 67 Inflammatory Waldenström's Macroglobulinemia

Clinical and Biological Features Of Multiple Myeloma (MM) and Monoclonal Gammopathies In Patients With Human Immunodeficiency Virus (HIV) Infection

Impact of Tandem Autologous/Non Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Relapsing After a First High Dose Therapy in the Era of Novels Anti-Myeloma Agents

Prognostic Value of the Different MMSET Gene Breakpoints and Correlation with Immunoglobulin Isotype and FGFR3 Expression in 173 Patients with t(4;14) Multiple Myeloma

Patients with POEMS Syndrome Have High Bone Turnover and Increased Circulating Angiogenic Cytokines; Should Angiopoietin-2 and Bone-Specific Alkaline Phosphatase Be Used As Minor Criteria for the Diagnosis of the Disease?

Total Body Irradiation (TBI) or Busulfan (Bu) Plus High Dose Melphalan After Bortezomib (Bz) Containing Regimen As Front Line Treatment of High Risk Multiple Myeloma (MM) Patients with 17p Deletion and/or t(4;14) Translocation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only